£520.00

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States

Price data checked 5 days ago

View at Amazon

Price History & Forecast

Last 86 days • 86 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 16 February 2026 09 March 2026 30 March 2026 21 April 2026

Price Distribution

Price distribution over 86 days • 1 price levels

Days at Price
86 days 0 22 43 65 86 £520 Days at Price

Price Analysis

Most common price: £520 (86 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 86 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in India
98% match

The 2023-2028 Outlook for Peripheral Neuropathy Treatments in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Diabetic Neuropathy in the United States
97% match

The 2023-2028 Outlook for Diabetic Neuropathy in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
97% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
97% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Plantar Fasciitis Treatments in the United States
97% match

The 2023-2028 Outlook for Plantar Fasciitis Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States
97% match

The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for External Neurostimulation in the United States
97% match

The 2023-2028 Outlook for External Neurostimulation in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
97% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
97% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments for US Zip Codes

£490.00 12 Jan 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
96% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Therapeutic Plasma Exchange for Neurological Disorders in the United States
96% match

The 2023-2028 Outlook for Therapeutic Plasma Exchange for Neurological Disorders in the United States

£520.00 09 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Negative Pressure Wound Therapy Devices in the United States
96% match

The 2023-2028 Outlook for Negative Pressure Wound Therapy Devices in the United States

£520.00 10 Feb 2026
The 2023-2028 Outlook for Diabetes Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetes Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Venous Leg Ulcer Treatments in the United States
96% match

The 2023-2028 Outlook for Venous Leg Ulcer Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Negative-Pressure Wound Therapies in the United States
96% match

The 2023-2028 Outlook for Negative-Pressure Wound Therapies in the United States

£520.00 10 Feb 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Neurostimulation Devices in the United States
96% match

The 2023-2028 Outlook for Neurostimulation Devices in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States

£520.00 07 Feb 2026